PL402324A1 - Nowe peptydomimetyki i ich zastosowanie - Google Patents
Nowe peptydomimetyki i ich zastosowanieInfo
- Publication number
- PL402324A1 PL402324A1 PL402324A PL40232412A PL402324A1 PL 402324 A1 PL402324 A1 PL 402324A1 PL 402324 A PL402324 A PL 402324A PL 40232412 A PL40232412 A PL 40232412A PL 402324 A1 PL402324 A1 PL 402324A1
- Authority
- PL
- Poland
- Prior art keywords
- application
- new peptidomimetics
- peptidomimetics
- new
- administration
- Prior art date
Links
- 239000000816 peptidomimetic Substances 0.000 title abstract 2
- 206010010774 Constipation Diseases 0.000 abstract 1
- 102000003840 Opioid Receptors Human genes 0.000 abstract 1
- 108090000137 Opioid Receptors Proteins 0.000 abstract 1
- 210000002249 digestive system Anatomy 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000007943 implant Substances 0.000 abstract 1
- 238000001802 infusion Methods 0.000 abstract 1
- -1 infusions Substances 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 229940005483 opioid analgesics Drugs 0.000 abstract 1
- 230000002093 peripheral effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Przedmiotem wynalazku są nowe peptydomimetyki wykazujące powinowactwo do receptorów opioidowych, o ogólnym wzorze 1, do podawania do układu pokarmowego lub podawania obwodowego w postaci tabletek, wlewów, iniekcji lub implantów do leczenia lub zapobiegania efektom ubocznym wywoływanym przez opioidy, w szczególności zaparciom i/lub depresji oddechowej.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL402324A PL223593B1 (pl) | 2012-12-31 | 2012-12-31 | Nowe peptydomimetyki i ich zastosowanie |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL402324A PL223593B1 (pl) | 2012-12-31 | 2012-12-31 | Nowe peptydomimetyki i ich zastosowanie |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL402324A1 true PL402324A1 (pl) | 2014-07-07 |
| PL223593B1 PL223593B1 (pl) | 2016-10-31 |
Family
ID=51063126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL402324A PL223593B1 (pl) | 2012-12-31 | 2012-12-31 | Nowe peptydomimetyki i ich zastosowanie |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL223593B1 (pl) |
-
2012
- 2012-12-31 PL PL402324A patent/PL223593B1/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL223593B1 (pl) | 2016-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12013501244A1 (en) | A combination of an opioid agonist and an opioid antagonist in the treatment of parkinson's disease | |
| MX2020010535A (es) | Inhibidor de ezh2 para usarse en el tratamiento de sarcoma epiteloide. | |
| IN2014DN10670A (pl) | ||
| IN2015KN00414A (pl) | ||
| UA110213C2 (en) | Use of sigma-ligand induced opioid hyperalgesia | |
| PH12014500468A1 (en) | Heterocyclic compounds and uses thereof | |
| JO3366B1 (ar) | مثبطات بيرازوليل كوينوكزالين كاينيز | |
| EP2528934A4 (en) | AROMATIC-CATIONIC PEPTIDES AND USES THEREOF | |
| IN2014MN00948A (pl) | ||
| PH12013501136A1 (en) | Lysophosphatidic acid receptor antagonists and uses thereof | |
| MX2013011908A (es) | Composiciones y usos terapeuticos de inhibidores de cinasa epsilon relacionados con cinasa i-kappa b (ikk) y cinasa 1 de union tank. | |
| PH12013500958A1 (en) | Piperidinone carboxamide azaindane cgrp receptor antagonists | |
| MX343534B (es) | Inhibidores de arginasa y sus aplicaciones terapeuticas. | |
| MX345535B (es) | Compuestos tricíclicos parcialmente saturados y métodos para su fabricación y su uso. | |
| IN2015DN03854A (pl) | ||
| PH12016500140A1 (en) | Heterobicycloaryl rorc2 inhibitors and methods of use thereof | |
| MX2014008706A (es) | Compuestos tricíclicos de sulfonamida y métodos para elaborarlos y usarlos. | |
| TN2012000488A1 (en) | Pharmaceutical compositions comprising hydromorphone and naloxone | |
| MX2014000964A (es) | Derivados aza heterociclicos sustituidos. | |
| MX2015012528A (es) | Inhibidores macrociclicos de cinasa inducibles por sal. | |
| MX366134B (es) | Angiotensina en el tratamiento de condiciones cerebrales. | |
| MX342947B (es) | Tratamiento de diabetes tipo 2. | |
| UA114417C2 (uk) | Інгібітори iap | |
| MX2015005732A (es) | Compuestos tricíclicos y métodos para hacer y utilizar los mismos. | |
| MY152040A (en) | Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments |